InsiderSignal.AI

InsiderSignal.ai

ORIC - Oric Pharmaceuticals, Inc.

Insider Sale by Piscitelli Dominic (CFO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Piscitelli Dominic, serving as CFO at Oric Pharmaceuticals, Inc. (ORIC), sold 52,000 shares at $13.51 per share, for a total transaction value of $702,686.00. Following this transaction, Piscitelli Dominic now holds 68,148 shares of ORIC.

This sale represents a 43.00% decrease in Piscitelli Dominic's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 2 days after the trade was made.

Oric Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Piscitelli Dominic

Piscitelli Dominic

CFO

Dominic Piscitelli is the Chief Financial Officer (CFO) of ORIC Pharmaceuticals, Inc. (ORIC), a clinical-stage oncology company focused on overcoming cancer treatment resistance, a role he has held since September 2019.[[1]](https://oricpharma.com/news/oric-pharmaceuticals-appoints-dominic-piscitelli-as-chief-financial-officer/)[[2]](https://fintool.com/app/research/companies/ORIC/people/dominic-piscitelli)[[4]](https://www.prnewswire.com/news-releases/oric-pharmaceuticals-appoints-dominic-piscitelli-as-chief-financial-officer-300914794.html) As CFO, he serves on the executive leadership team, leading finance, investor relations, and corporate operations functions.[[1]](https://oricpharma.com/news/oric-pharmaceuticals-appoints-dominic-piscitelli-as-chief-financial-officer/)[[4]](https://www.prnewswire.com/news-releases/oric-pharmaceuticals-appoints-dominic-piscitelli-as-chief-financial-officer-300914794.html) Recently, on January 2, 2026, he received equity compensation including stock options for 206,500 shares at $8.17 per share and 34,500 RSUs with multi-year vesting schedules.[[3]](https://www.stocktitan.net/sec-filings/ORIC/form-4-oric-pharmaceuticals-inc-insider-trading-activity-43ddd224c4c2.html) Piscitelli, age 51, brings over 20 years of biotechnology industry experience, including debt and equity financings, acquisitions, and commercial launches of products like XTANDI® and Tarceva®.[[1]](https://oricpharma.com/news/oric-pharmaceuticals-appoints-dominic-piscitelli-as-chief-financial-officer/)[[2]](https://fintool.com/app/research/companies/ORIC/people/dominic-piscitelli)[[6]](https://www.zoominfo.com/p/Dominic-Piscitelli/1609891087) His career highlights include serving as CFO of AnaptysBio, where he raised over $500 million through IPO and follow-on financings; Vice President of Finance, Strategy, and Investor Relations at Medivation, contributing to its acquisition by Pfizer; and roles at Astellas Pharma and OSI Pharmaceuticals, aiding OSI's acquisition by Astellas.[[1]](https://oricpharma.com/news/oric-pharmaceuticals-appoints-dominic-piscitelli-as-chief-financial-officer/) He began his career at KPMG as a certified public accountant and holds a bachelor’s degree in accounting and an MBA from Hofstra University.[[1]](https://oricpharma.com/news/oric-pharmaceuticals-appoints-dominic-piscitelli-as-chief-financial-officer/)[[2]](https://fintool.com/app/research/companies/ORIC/people/dominic-piscitelli)

View full insider profile →

Trade Price

$13.51

Quantity

52,000

Total Value

$702,686.00

Shares Owned

68,148

Trade Date

Tuesday, February 24, 2026

3 days ago

SEC Filing Date

Thursday, February 26, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Oric Pharmaceuticals, Inc.

Company Overview

No company information available
View news mentioning ORIC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4325052

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime